NCT06683248

Brief Summary

The study aims to investigate the effects of sleep deprivation on women's health across different phases of the menstrual cycle.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 25, 2022

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

October 15, 2024

Completed
28 days until next milestone

First Posted

Study publicly available on registry

November 12, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

November 14, 2024

Status Verified

November 1, 2024

Enrollment Period

2.7 years

First QC Date

October 15, 2024

Last Update Submit

November 11, 2024

Conditions

Keywords

Estrogen

Outcome Measures

Primary Outcomes (21)

  • The effect of sleep deprivation vs sleep on brain health across the menstrual cycle

    Blood analysis for neurodegenerative biomarkers, specifically Tau protein phosphorylated at amino acid 181 and 231, Aβ40 and Aβ42, GFAP, NfL.

    1 year

  • The effects of sleep deprivation across the menstrual cycle on EEG

    The Dreem headband will be used to record EEG, assessing wakefulness levels during the sleep deprivation night through spectral power analysis. It will also be used to generate a hypnogram for sleep stage classification.

    1 year

  • The effects of sleep deprivation on metabolic function (TEE)

    Energy Expenditure is measured with the K5 wearable system to monitor VO₂ and VCO₂ in real-time, assessing total energy expenditure (TEE).

    2 years

  • The effects of sleep deprivation on glucose metabolism

    Assessed with an Oral Glucose Tolerance Test (OGTT) and continuous blood glucose monitoring.

    1 year

  • The effects of sleep deprivation on leptin/adiponectin ratio

    Blood analysis to assess the ratio of leptin/adiponectin for metabolic health throughout the menstrual cycle.

    2 years

  • The effects of sleep deprivation on vaginal microbiota identification across the menstrual cycle

    Identification and comparison of bacterial species composition and diversity (alpha- and beta-diversity)

    2 years

  • The effects of sleep deprivation on vaginal microbiota classification across the menstrual cycle

    Classification of community state types (CST)

    2 years

  • The effects of sleep deprivation on vaginal microbiota across the menstrual cycle

    Changes in total phage content

    2 years

  • The effect of sleep deprivation on stress response across the menstrual cycle

    An auditory paradigm for stress induction will employ eye tracking to monitor changes in pupil dilation.

    2 years

  • The effect of sleep deprivation on stress response across the menstrual cycle

    Galvanic skin response measures the electrical characteristics or conductance of the skin as an indirect measure of sympathetic autonomic activity using the change of electrical properties of skin measured continuously throughout an auditory paradigm designed to induce stress.

    2 years

  • The effect of sleep deprivation on stress response across the menstrual cycle

    Heart rate is tracked to assess autonomic responses to stress throughout the auditory paradigm for stress induction.

    2 years

  • The effects of sleep deprivation on immune system profiling across menstrual cycle

    Human blood samples are analyzed to determine the levels of proangiogenic neutrophils characterized as CD45+CD3-CD19-CD16+CD49d+VEGFR1+. Additionally, the presence of cytotoxic natural killer (NK) cells defined as CD56dim, CD16+, CX3CR1+, CCR7-, CXCR4dim, and CD57+, alongside non-cytotoxic NK cells, which are identified as CD56bright, CD16-, CX3CR1-, CCR7+, CXCR4 high, and CD57-. The cellular populations are expressed as a percentage of CD45+ positive cells, reflecting the total leukocyte population in the blood. To quantify these cell types, the leukocytes are isolated through gradient centrifugation and analyzed using spectral flow cytometry following incubation with two multicolor antibody panels. The technique used is FACS, fluorescence-activated cell sorting.

    3 years

  • The levels of 6-sulfatoxymelatonin across the menstrual cycle during sleep and sleep deprivation conditions

    Urine levels measured 6-sulfatoxymelatonin during both sleep and sleep deprivation condition

    2 years

  • The effects of sleep vs sleep deprivation on ABI across the menstrual cycle

    Ankle-Brachial Index (ABI) assessed by comparing blood pressure in legs and arms.

    1 year

  • The effects of sleep deprivation on palatability across the menstrual cycle

    Subjective rating of palatability for food items on a Visual Analogue Scale (VAS). Scale Range: 0 to 100, with 0 indicating "not at all palatable" and 100 indicating "extremely palatable." Higher scores indicate greater palatability, potentially signaling increased appeal for certain foods/calories following sleep deprivation, typically viewed as an adverse outcome.

    2 years

  • The effects of sleep deprivation on appetite across the menstrual cycle

    Blood analysis for leptin/ghrelin ratio

    2 years

  • The effects of sleep deprivation on food arousal across the menstrual cycle

    Food arousal response will be assessed using an eye tracker to analyze changes in pupil dilation.

    2 years

  • The effects of sleep deprivation on hunger across the menstrual cycle

    A portion size task is administered to the participant on the morning following both sleep and sleep deprivation conditions to assess hunger. Hunger will be measured by the total caloric content of food portions selected by the participant during the task.

    2 years

  • The effects of sleep deprivation on psychomotor vigilance across the menstrual cycle

    The Psychomotor Vigilance Task (PVT) is a visual reaction time test used to objectively assess sustained attention and alertness. Participants respond as quickly as possible to visual stimuli, with mean reaction time and the number of lapses (missed responses) serving as key outcome measures that reflect cognitive performance, particularly in conditions like sleep deprivation or fatigue.

    2 years

  • The effect of salivary cortisol on sleep vs sleep deprivation across the menstrual cycle

    Salivary cortisol samples will be collected during the sleep deprivation night and on the following morning after both sleep and sleep deprivation conditions to investigate cortisol levels in response to sleep loss across menstrual cycle.

    2 years

  • Oral microbiota changes across menstrual cycle and sleep deprivation

    Analyze the changes in the oral microbiota across the menstrual cycle in sleep and sleep deprivation conditions by investigating shifts in microbial composition, diversity, and the abundance of bacteria. This could provide insights into how sleep patterns and menstrual phases interact to impact oral health.

    4 years

Study Arms (1)

Sleep deprivation

EXPERIMENTAL

All participants will undergo an 8-hour sleep opportunity, immediately followed by a night of total sleep deprivation.

Other: Investigate sleep deprivation

Interventions

Sleep deprivation Devices used: Dreem band for EEG Actiheart Tobii Eye tracker Blood glucose monitor Blood pressure cuff Mira fertility tracker Galvanic skin response K5: wearable metabolic system Fitbit: wearable technology Withings sleep analyzer Body composition monitor

Sleep deprivation

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • \- Healthy

You may not qualify if:

  • Use of hormonal contraceptives
  • Chronic disease
  • Regular use of nicotine
  • Use of medication
  • Consumes excessive amounts of alcohol or coffee

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uppsala University

Uppsala, Uppsala County, 751 23, Sweden

RECRUITING

MeSH Terms

Conditions

Sleep Deprivation

Condition Hierarchy (Ancestors)

DyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Central Study Contacts

Meth

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior lecturer

Study Record Dates

First Submitted

October 15, 2024

First Posted

November 12, 2024

Study Start

April 25, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2025

Last Updated

November 14, 2024

Record last verified: 2024-11

Locations